FMR1 and fragile X syndrome: Notably, genetic reduction of these signaling molecules corrects the elevation of global protein synthesis and certain behavioral symptoms in the FXS mouse model (i.e., Fmr1 knockout [KO] mice) (Dolen et al., 2007; Bhattacharya et al., 2012; Gross et al., 2015).